Norges Bank’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,213,637
| Closed | -$1.66M | – | 1229 |
|
|
2024
Q2 | $1.66M | Sell |
1,213,637
-338,940
| -22% | -$464K | ﹤0.01% | 1752 |
|
|
2024
Q1 | $5.82M | Buy |
1,552,577
+177,862
| +13% | +$667K | ﹤0.01% | 1588 |
|
|
2023
Q4 | $13.5M | Sell |
1,374,715
-11,090
| -0.8% | -$109K | ﹤0.01% | 1388 |
|
|
2023
Q3 | $11.6M | Sell |
1,385,805
-120,416
| -8% | -$1.01M | ﹤0.01% | 1417 |
|
|
2023
Q2 | $20M | Buy |
1,506,221
+317,400
| +27% | +$4.22M | ﹤0.01% | 1258 |
|
|
2023
Q1 | $13.8M | Sell |
1,188,821
-508,706
| -30% | -$5.89M | ﹤0.01% | 1437 |
|
|
2022
Q4 | $13.9M | Hold |
1,697,527
| – | – | ﹤0.01% | 1439 |
|
|
2022
Q3 | $9.85M | Buy |
1,697,527
+448,468
| +36% | +$2.6M | ﹤0.01% | 1546 |
|
|
2022
Q2 | $5.52M | Sell |
1,249,059
-32,908
| -3% | -$145K | ﹤0.01% | 1746 |
|
|
2022
Q1 | $11.7M | Sell |
1,281,967
-444,602
| -26% | -$4.05M | ﹤0.01% | 1647 |
|
|
2021
Q4 | $35.3M | Buy |
1,726,569
+532,100
| +45% | +$10.9M | 0.01% | 1130 |
|
|
2021
Q3 | $30.5M | Sell |
1,194,469
-307,672
| -20% | -$7.86M | 0.01% | 1207 |
|
|
2021
Q2 | $52.5M | Sell |
1,502,141
-150,470
| -9% | -$5.26M | 0.01% | 937 |
|
|
2021
Q1 | $55M | Buy |
1,652,611
+1,532,796
| +1,279% | +$51.1M | 0.01% | 917 |
|
|
2020
Q4 | $3.11M | Buy |
+119,815
| New | +$3.11M | ﹤0.01% | 1918 |
|